CSF2 and neoplasm: GM-CSF-driven upregulation of prostaglandin E2 (PGE2) expression in MDSCs (138) can potentially suppress effector functions of macrophages, cytotoxic T and NK cells and promote pro-tumor Th2, Th17, and Treg responses (156).